Detalhe da pesquisa
1.
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med
; 386(20): 1910-1921, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320659
2.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med
; 385(19): 1761-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525277
3.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med
; 383(27): 2603-2615, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301246
4.
Chronic arthritides and bone structure: focus on rheumatoid arthritis-an update.
Aging Clin Exp Res
; 35(7): 1405-1416, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222927
5.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283213
6.
Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update : This manuscript has been produced under the auspices of the Committee of National Societies (CNS) and the Committee of Scientific Advisors (CSA) of the International Osteoporosis Foundation (IOF).
Aging Clin Exp Res
; 34(11): 2591-2602, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348222
7.
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.
Ann Rheum Dis
; 80(3): 304-311, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33115760
8.
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis.
Ann Rheum Dis
; 80(4): 432-439, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148701
9.
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
Clin Exp Rheumatol
; 38(4): 732-741, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452344
10.
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
Clin Exp Rheumatol
; 38(5): 848-857, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858963
11.
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet
; 391(10117): 230-240, 2018 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129436
12.
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
N Engl J Med
; 375(16): 1532-1543, 2016 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641143
13.
Argentine Guidelines for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Postmenopausal Women and Men Aged 50 Years and Older.
J Clin Rheumatol
; 30(2): e74-e75, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550851
14.
Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys.
Health Qual Life Outcomes
; 16(1): 211, 2018 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413162
15.
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Rheumatol Int
; 37(9): 1469-1479, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28597306
16.
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs.
Ann Rheum Dis
; 75(7): 1293-301, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275429
17.
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
Rheumatology (Oxford)
; 55(8): 1466-76, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27114562
18.
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
JAMA
; 316(7): 722-33, 2016 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533157
19.
Teriparatide vs risedronate for osteoporosis - Authors' reply.
Lancet
; 391(10133): 1896, 2018 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29781442
20.
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial.
Lancet
; 381(9865): 451-60, 2013 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23294500